Speech-Language Therapy
Treatment for Down Syndrome
Typical Dosage: 1-3 sessions/week (30-60 min/session)
Effectiveness
75%
Safety Score
95%
Clinical Trials
5
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
1-3 sessions/week (30-60 min/session)
Time to Effect
3-6 months
Treatment Duration
long-term (varying intensity)
Evidence Quality
MODERATEConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$0
Total Annual:$500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.5
Outcome-Based Costs
Cost per Responder
$7,142.86
Speech-Language Therapy Outcomes
for Down Syndrome
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+70%
Common Side Effects
Fatigue
+3%
Frustration
+2%
Sources:
Active Clinical Trials
2 active trials recruiting for Speech-Language Therapy in Down Syndrome
Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.
NCT07044804RECRUITINGNA
36 participants
INTERVENTIONAL
Rome, Italy
Started: Jan 27, 2025
Oromyofunctional Therapy: a Rehabilitation Program for OSA in Children With Down Syndrome and Prader-Willi Syndrome
NCT07122505RECRUITINGNA
60 participants
INTERVENTIONAL
Ghent, Belgium
Started: Apr 15, 2024
Completed Clinical Trials
2 completed trials for Speech-Language Therapy in Down Syndrome
Augmentative and Alternative Communication (AAC) and Lexical Gain in Children With Down Syndrome
NCT00689988COMPLETEDNA
5 participants
INTERVENTIONAL
São Paulo, Brazil
Started: Jul 1, 2005
Phenotypic Specific Communication Intervention for Children With Down Syndrome
NCT02158390COMPLETEDNA
78 participants
INTERVENTIONAL
Los Angeles, United States +1 more
Started: Jun 1, 2014